Literature DB >> 8777865

Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis.

A Spadaro, V Riccieri, A Sili Scavalli, F Sensi, E Taccari, A Zoppini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8777865     DOI： 10.1007/bf02230349

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  The soluble interleukin-2 receptor in rheumatic disease.

Authors:  L A Rubin
Journal:  Arthritis Rheum       Date:  1990-08

2.  Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.

Authors:  R P Polisson; M A Dooley; D V Dawson; D S Pisetsky
Journal:  Arthritis Rheum       Date:  1994-01

3.  Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

Authors:  B Dasgupta; M Corkill; B Kirkham; T Gibson; G Panayi
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

4.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

5.  Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

Authors:  P Barrera; A M Boerbooms; E M Janssen; R W Sauerwein; H Gallati; J Mulder; T de Boo; P N Demacker; L B van de Putte; J W van der Meer
Journal:  Arthritis Rheum       Date:  1993-08

6.  One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors.

Authors:  A Spadaro; V Riccieri; A Sili Scavalli; E Taccari; A Zoppini
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980
  6 in total
  1 in total

1.  Successful methotrexate therapy for adult Still's disease with marked thrombocytopenia.

Authors:  M Yamaguchi; Y Matsukawa; N Takahashi; M Takei; Y Tomita; S Nishinarita; T Horie
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.